News for Anebulo Pharmaceuticals, Inc. (ANEB)

Utah-based Sintx Technologies, Inc. (SINT) is up over 87 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Significant Stock Transaction by Nantahala Capital Management, LLC (Trades, Portfolio) On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfoli

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induc

Anebulo Pharmaceuticals sees $9.99m stock acquisition by 22NW fund

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid

Anebulo Pharmaceuticals receives NIDA grant for drug development

Lifecore Biomedical Announces Cooperation Agreement with 22NW

ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.21%

Here is how Anebulo Pharmaceuticals, Inc. (ANEB) and Conmed (CNMD) have performed compared to their sector so far this year.

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents